(2R)-2-(2-cyclopropylethyl)-4-propan-2-ylmorpholine;(2S)-2-(2-cyclopropylethyl)-4-propan-2-ylmorpholine;3-[[cyclopropyl(methyl)amino]methyl]-1-propan-2-ylpiperidin-3-ol;(3S)-3-[[cyclopropyl(methyl)amino]methyl]-1-propan-2-ylpiperidin-3-ol;(3R)-3-[[cyclopropyl(methyl)amino]methyl]-1-propan-2-ylpiperidin-3-ol;N,N-dimethyl-2-(4-propan-2-yloxan-4-yl)oxyethanamine;4-ethyl-3,3-difluoro-1-propan-2-ylpiperidine;(4S)-4-ethyl-3,3-difluoro-1-propan-2-ylpiperidine;(4R)-4-ethyl-3,3-difluoro-1-propan-2-ylpiperidine;(4-methoxy-1-propan-2-ylpiperidin-4-yl)methanol;(2R)-2-(2-methoxypropan-2-yl)-4-propan-2-ylmorpholine;(2S)-2-(2-methoxypropan-2-yl)-4-propan-2-ylmorpholine;2-(2-methoxypropan-2-yl)-4-propan-2-ylmorpholine;3-propan-2-yloxane;(3R)-3-propan-2-yloxane;(3S)-3-propan-2-yloxane

C172H344F6N16O18 — CID 167649954

IUPAC(2R)-2-(2-cyclopropylethyl)-4-propan-2-ylmorpholine;(2S)-2-(2-cyclopropylethyl)-4-propan-2-ylmorpholine;3-[[cyclopropyl(methyl)amino]methyl]-1-propan-2-ylpiperidin-3-ol;(3S)-3-[[cyclopropyl(methyl)amino]methyl]-1-propan-2-ylpiperidin-3-ol;(3R)-3-[[cyclopropyl(methyl)amino]methyl]-1-propan-2-ylpiperidin-3-ol;N,N-dimethyl-2-(4-propan-2-yloxan-4-yl)oxyethanamine;4-ethyl-3,3-difluoro-1-propan-2-ylpiperidine;(4S)-4-ethyl-3,3-difluoro-1-propan-2-ylpiperidine;(4R)-4-ethyl-3,3-difluoro-1-propan-2-ylpiperidine;(4-methoxy-1-propan-2-ylpiperidin-4-yl)methanol;(2R)-2-(2-methoxypropan-2-yl)-4-propan-2-ylmorpholine;(2S)-2-(2-methoxypropan-2-yl)-4-propan-2-ylmorpholine;2-(2-methoxypropan-2-yl)-4-propan-2-ylmorpholine;3-propan-2-yloxane;(3R)-3-propan-2-yloxane;(3S)-3-propan-2-yloxane
SMILESCC(C)C1(OCCN(C)C)CCOCC1.CC(C)C1CCCOC1.CC(C)C1CCCOC1.CC(C)N1CCCC(O)(CN(C)C2CC2)C1.CC(C)N1CCC[C@@](O)(CN(C)C2CC2)C1.CC(C)N1CCC[C@](O)(CN(C)C2CC2)C1.CC(C)N1CCO[C@@H](CCC2CC2)C1.CC(C)N1CCO[C@H](CCC2CC2)C1.CC(C)[C@@H]1CCCOC1.CCC1CCN(C(C)C)CC1(F)F.CC[C@@H]1CCN(C(C)C)CC1(F)F.CC[C@H]1CCN(C(C)C)CC1(F)F.COC(C)(C)C1CN(C(C)C)CCO1.COC(C)(C)[C@@H]1CN(C(C)C)CCO1.COC(C)(C)[C@H]1CN(C(C)C)CCO1.COC1(CO)CCN(C(C)C)CC1
InChIInChI=1S/3C13H26N2O.C12H25NO2.2C12H23NO.3C11H23NO2.3C10H19F2N.C10H21NO2.3C8H16O/c3*1-11(2)15-8-4-7-13(16,10-15)9-14(3)12-5-6-12;1-11(2)12(5-8-14-9-6-12)15-10-7-13(3)4;2*1-10(2)13-7-8-14-12(9-13)6-5-11-3-4-11;3*1-9(2)12-6-7-14-10(8-12)11(3,4)13-5;3*1-4-9-5-6-13(8(2)3)7-10(9,11)12;1-9(2)11-6-4-10(8-12,13-3)5-7-11;3*1-7(2)8-4-3-5-9-6-8/h3*11-12,16H,4-10H2,1-3H3;11H,5-10H2,1-4H3;2*10-12H,3-9H2,1-2H3;3*9-10H,6-8H2,1-5H3;3*8-9H,4-7H2,1-3H3;9,12H,4-8H2,1-3H3;3*7-8H,3-6H2,1-2H3/t2*13-;;;2*12-;2*10-;;2*9-;;;8-;;/m10..1010.10..1../s1
InChIKeyQKUAJTYQLPKVBY-ZDUIGDSTSA-N
MW3038.73 g/mol
LogP30.21
Rot. Bonds46

About (2R)-2-(2-cyclopropylethyl)-4-propan-2-ylmorpholine;(2S)-2-(2-cyclopropylethyl)-4-propan-2-ylmorpholine;3-[[cyclopropyl(methyl)amino]methyl]-1-propan-2-ylpiperidin-3-ol;(3S)-3-[[cyclopropyl(methyl)amino]methyl]-1-propan-2-ylpiperidin-3-ol;(3R)-3-[[cyclopropyl(methyl)amino]methyl]-1-propan-2-ylpiperidin-3-ol;N,N-dimethyl-2-(4-propan-2-yloxan-4-yl)oxyethanamine;4-ethyl-3,3-difluoro-1-propan-2-ylpiperidine;(4S)-4-ethyl-3,3-difluoro-1-propan-2-ylpiperidine;(4R)-4-ethyl-3,3-difluoro-1-propan-2-ylpiperidine;(4-methoxy-1-propan-2-ylpiperidin-4-yl)methanol;(2R)-2-(2-methoxypropan-2-yl)-4-propan-2-ylmorpholine;(2S)-2-(2-methoxypropan-2-yl)-4-propan-2-ylmorpholine;2-(2-methoxypropan-2-yl)-4-propan-2-ylmorpholine;3-propan-2-yloxane;(3R)-3-propan-2-yloxane;(3S)-3-propan-2-yloxane

(2R)-2-(2-cyclopropylethyl)-4-propan-2-ylmorpholine;(2S)-2-(2-cyclopropylethyl)-4-propan-2-ylmorpholine;3-[[cyclopropyl(methyl)amino]methyl]-1-propan-2-ylpiperidin-3-ol;(3S)-3-[[cyclopropyl(methyl)amino]methyl]-1-propan-2-ylpiperidin-3-ol;(3R)-3-[[cyclopropyl(methyl)amino]methyl]-1-propan-2-ylpiperidin-3-ol;N,N-dimethyl-2-(4-propan-2-yloxan-4-yl)oxyethanamine;4-ethyl-3,3-difluoro-1-propan-2-ylpiperidine;(4S)-4-ethyl-3,3-difluoro-1-propan-2-ylpiperidine;(4R)-4-ethyl-3,3-difluoro-1-propan-2-ylpiperidine;(4-methoxy-1-propan-2-ylpiperidin-4-yl)methanol;(2R)-2-(2-methoxypropan-2-yl)-4-propan-2-ylmorpholine;(2S)-2-(2-methoxypropan-2-yl)-4-propan-2-ylmorpholine;2-(2-methoxypropan-2-yl)-4-propan-2-ylmorpholine;3-propan-2-yloxane;(3R)-3-propan-2-yloxane;(3S)-3-propan-2-yloxane (PubChem CID 167649954) has the molecular formula C172H344F6N16O18 and a molecular weight of 3038.73 g/mol. Its IUPAC name is (2R)-2-(2-cyclopropylethyl)-4-propan-2-ylmorpholine;(2S)-2-(2-cyclopropylethyl)-4-propan-2-ylmorpholine;3-[[cyclopropyl(methyl)amino]methyl]-1-propan-2-ylpiperidin-3-ol;(3S)-3-[[cyclopropyl(methyl)amino]methyl]-1-propan-2-ylpiperidin-3-ol;(3R)-3-[[cyclopropyl(methyl)amino]methyl]-1-propan-2-ylpiperidin-3-ol;N,N-dimethyl-2-(4-propan-2-yloxan-4-yl)oxyethanamine;4-ethyl-3,3-difluoro-1-propan-2-ylpiperidine;(4S)-4-ethyl-3,3-difluoro-1-propan-2-ylpiperidine;(4R)-4-ethyl-3,3-difluoro-1-propan-2-ylpiperidine;(4-methoxy-1-propan-2-ylpiperidin-4-yl)methanol;(2R)-2-(2-methoxypropan-2-yl)-4-propan-2-ylmorpholine;(2S)-2-(2-methoxypropan-2-yl)-4-propan-2-ylmorpholine;2-(2-methoxypropan-2-yl)-4-propan-2-ylmorpholine;3-propan-2-yloxane;(3R)-3-propan-2-yloxane;(3S)-3-propan-2-yloxane.

Molecular Properties

Compound Name(2R)-2-(2-cyclopropylethyl)-4-propan-2-ylmorpholine;(2S)-2-(2-cyclopropylethyl)-4-propan-2-ylmorpholine;3-[[cyclopropyl(methyl)amino]methyl]-1-propan-2-ylpiperidin-3-ol;(3S)-3-[[cyclopropyl(methyl)amino]methyl]-1-propan-2-ylpiperidin-3-ol;(3R)-3-[[cyclopropyl(methyl)amino]methyl]-1-propan-2-ylpiperidin-3-ol;N,N-dimethyl-2-(4-propan-2-yloxan-4-yl)oxyethanamine;4-ethyl-3,3-difluoro-1-propan-2-ylpiperidine;(4S)-4-ethyl-3,3-difluoro-1-propan-2-ylpiperidine;(4R)-4-ethyl-3,3-difluoro-1-propan-2-ylpiperidine;(4-methoxy-1-propan-2-ylpiperidin-4-yl)methanol;(2R)-2-(2-methoxypropan-2-yl)-4-propan-2-ylmorpholine;(2S)-2-(2-methoxypropan-2-yl)-4-propan-2-ylmorpholine;2-(2-methoxypropan-2-yl)-4-propan-2-ylmorpholine;3-propan-2-yloxane;(3R)-3-propan-2-yloxane;(3S)-3-propan-2-yloxane
PubChem CID167649954
Molecular FormulaC172H344F6N16O18
Molecular Weight3038.73 g/mol
Exact Mass3036.64
IUPAC Name(2R)-2-(2-cyclopropylethyl)-4-propan-2-ylmorpholine;(2S)-2-(2-cyclopropylethyl)-4-propan-2-ylmorpholine;3-[[cyclopropyl(methyl)amino]methyl]-1-propan-2-ylpiperidin-3-ol;(3S)-3-[[cyclopropyl(methyl)amino]methyl]-1-propan-2-ylpiperidin-3-ol;(3R)-3-[[cyclopropyl(methyl)amino]methyl]-1-propan-2-ylpiperidin-3-ol;N,N-dimethyl-2-(4-propan-2-yloxan-4-yl)oxyethanamine;4-ethyl-3,3-difluoro-1-propan-2-ylpiperidine;(4S)-4-ethyl-3,3-difluoro-1-propan-2-ylpiperidine;(4R)-4-ethyl-3,3-difluoro-1-propan-2-ylpiperidine;(4-methoxy-1-propan-2-ylpiperidin-4-yl)methanol;(2R)-2-(2-methoxypropan-2-yl)-4-propan-2-ylmorpholine;(2S)-2-(2-methoxypropan-2-yl)-4-propan-2-ylmorpholine;2-(2-methoxypropan-2-yl)-4-propan-2-ylmorpholine;3-propan-2-yloxane;(3R)-3-propan-2-yloxane;(3S)-3-propan-2-yloxane
SMILESCC(C)C1(OCCN(C)C)CCOCC1.CC(C)C1CCCOC1.CC(C)C1CCCOC1.CC(C)N1CCCC(O)(CN(C)C2CC2)C1.CC(C)N1CCC[C@@](O)(CN(C)C2CC2)C1.CC(C)N1CCC[C@](O)(CN(C)C2CC2)C1.CC(C)N1CCO[C@@H](CCC2CC2)C1.CC(C)N1CCO[C@H](CCC2CC2)C1.CC(C)[C@@H]1CCCOC1.CCC1CCN(C(C)C)CC1(F)F.CC[C@@H]1CCN(C(C)C)CC1(F)F.CC[C@H]1CCN(C(C)C)CC1(F)F.COC(C)(C)C1CN(C(C)C)CCO1.COC(C)(C)[C@@H]1CN(C(C)C)CCO1.COC(C)(C)[C@H]1CN(C(C)C)CCO1.COC1(CO)CCN(C(C)C)CC1
InChIInChI=1S/3C13H26N2O.C12H25NO2.2C12H23NO.3C11H23NO2.3C10H19F2N.C10H21NO2.3C8H16O/c3*1-11(2)15-8-4-7-13(16,10-15)9-14(3)12-5-6-12;1-11(2)12(5-8-14-9-6-12)15-10-7-13(3)4;2*1-10(2)13-7-8-14-12(9-13)6-5-11-3-4-11;3*1-9(2)12-6-7-14-10(8-12)11(3,4)13-5;3*1-4-9-5-6-13(8(2)3)7-10(9,11)12;1-9(2)11-6-4-10(8-12,13-3)5-7-11;3*1-7(2)8-4-3-5-9-6-8/h3*11-12,16H,4-10H2,1-3H3;11H,5-10H2,1-4H3;2*10-12H,3-9H2,1-2H3;3*9-10H,6-8H2,1-5H3;3*8-9H,4-7H2,1-3H3;9,12H,4-8H2,1-3H3;3*7-8H,3-6H2,1-2H3/t2*13-;;;2*12-;2*10-;;2*9-;;;8-;;/m10..1010.10..1../s1
InChIKeyQKUAJTYQLPKVBY-ZDUIGDSTSA-N
XLogP30.21
TPSA261.98 Ų
H-Bond Donors4
H-Bond Acceptors34
Rotatable Bonds46
Heavy Atoms212
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5003038.73
LogP ≤ 530.21
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1034

Analyze (2R)-2-(2-cyclopropylethyl)-4-propan-2-ylmorpholine;(2S)-2-(2-cyclopropylethyl)-4-propan-2-ylmorpholine;3-[[cyclopropyl(methyl)amino]methyl]-1-propan-2-ylpiperidin-3-ol;(3S)-3-[[cyclopropyl(methyl)amino]methyl]-1-propan-2-ylpiperidin-3-ol;(3R)-3-[[cyclopropyl(methyl)amino]methyl]-1-propan-2-ylpiperidin-3-ol;N,N-dimethyl-2-(4-propan-2-yloxan-4-yl)oxyethanamine;4-ethyl-3,3-difluoro-1-propan-2-ylpiperidine;(4S)-4-ethyl-3,3-difluoro-1-propan-2-ylpiperidine;(4R)-4-ethyl-3,3-difluoro-1-propan-2-ylpiperidine;(4-methoxy-1-propan-2-ylpiperidin-4-yl)methanol;(2R)-2-(2-methoxypropan-2-yl)-4-propan-2-ylmorpholine;(2S)-2-(2-methoxypropan-2-yl)-4-propan-2-ylmorpholine;2-(2-methoxypropan-2-yl)-4-propan-2-ylmorpholine;3-propan-2-yloxane;(3R)-3-propan-2-yloxane;(3S)-3-propan-2-yloxane with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2R)-2-(2-cyclopropylethyl)-4-propan-2-ylmorpholine;(2S)-2-(2-cyclopropylethyl)-4-propan-2-ylmorpholine;3-[[cyclopropyl(methyl)amino]methyl]-1-propan-2-ylpiperidin-3-ol;(3S)-3-[[cyclopropyl(methyl)amino]methyl]-1-propan-2-ylpiperidin-3-ol;(3R)-3-[[cyclopropyl(methyl)amino]methyl]-1-propan-2-ylpiperidin-3-ol;N,N-dimethyl-2-(4-propan-2-yloxan-4-yl)oxyethanamine;4-ethyl-3,3-difluoro-1-propan-2-ylpiperidine;(4S)-4-ethyl-3,3-difluoro-1-propan-2-ylpiperidine;(4R)-4-ethyl-3,3-difluoro-1-propan-2-ylpiperidine;(4-methoxy-1-propan-2-ylpiperidin-4-yl)methanol;(2R)-2-(2-methoxypropan-2-yl)-4-propan-2-ylmorpholine;(2S)-2-(2-methoxypropan-2-yl)-4-propan-2-ylmorpholine;2-(2-methoxypropan-2-yl)-4-propan-2-ylmorpholine;3-propan-2-yloxane;(3R)-3-propan-2-yloxane;(3S)-3-propan-2-yloxane?
The IUPAC name of (2R)-2-(2-cyclopropylethyl)-4-propan-2-ylmorpholine;(2S)-2-(2-cyclopropylethyl)-4-propan-2-ylmorpholine;3-[[cyclopropyl(methyl)amino]methyl]-1-propan-2-ylpiperidin-3-ol;(3S)-3-[[cyclopropyl(methyl)amino]methyl]-1-propan-2-ylpiperidin-3-ol;(3R)-3-[[cyclopropyl(methyl)amino]methyl]-1-propan-2-ylpiperidin-3-ol;N,N-dimethyl-2-(4-propan-2-yloxan-4-yl)oxyethanamine;4-ethyl-3,3-difluoro-1-propan-2-ylpiperidine;(4S)-4-ethyl-3,3-difluoro-1-propan-2-ylpiperidine;(4R)-4-ethyl-3,3-difluoro-1-propan-2-ylpiperidine;(4-methoxy-1-propan-2-ylpiperidin-4-yl)methanol;(2R)-2-(2-methoxypropan-2-yl)-4-propan-2-ylmorpholine;(2S)-2-(2-methoxypropan-2-yl)-4-propan-2-ylmorpholine;2-(2-methoxypropan-2-yl)-4-propan-2-ylmorpholine;3-propan-2-yloxane;(3R)-3-propan-2-yloxane;(3S)-3-propan-2-yloxane (CID 167649954) is (2R)-2-(2-cyclopropylethyl)-4-propan-2-ylmorpholine;(2S)-2-(2-cyclopropylethyl)-4-propan-2-ylmorpholine;3-[[cyclopropyl(methyl)amino]methyl]-1-propan-2-ylpiperidin-3-ol;(3S)-3-[[cyclopropyl(methyl)amino]methyl]-1-propan-2-ylpiperidin-3-ol;(3R)-3-[[cyclopropyl(methyl)amino]methyl]-1-propan-2-ylpiperidin-3-ol;N,N-dimethyl-2-(4-propan-2-yloxan-4-yl)oxyethanamine;4-ethyl-3,3-difluoro-1-propan-2-ylpiperidine;(4S)-4-ethyl-3,3-difluoro-1-propan-2-ylpiperidine;(4R)-4-ethyl-3,3-difluoro-1-propan-2-ylpiperidine;(4-methoxy-1-propan-2-ylpiperidin-4-yl)methanol;(2R)-2-(2-methoxypropan-2-yl)-4-propan-2-ylmorpholine;(2S)-2-(2-methoxypropan-2-yl)-4-propan-2-ylmorpholine;2-(2-methoxypropan-2-yl)-4-propan-2-ylmorpholine;3-propan-2-yloxane;(3R)-3-propan-2-yloxane;(3S)-3-propan-2-yloxane.
What is the SMILES notation for (2R)-2-(2-cyclopropylethyl)-4-propan-2-ylmorpholine;(2S)-2-(2-cyclopropylethyl)-4-propan-2-ylmorpholine;3-[[cyclopropyl(methyl)amino]methyl]-1-propan-2-ylpiperidin-3-ol;(3S)-3-[[cyclopropyl(methyl)amino]methyl]-1-propan-2-ylpiperidin-3-ol;(3R)-3-[[cyclopropyl(methyl)amino]methyl]-1-propan-2-ylpiperidin-3-ol;N,N-dimethyl-2-(4-propan-2-yloxan-4-yl)oxyethanamine;4-ethyl-3,3-difluoro-1-propan-2-ylpiperidine;(4S)-4-ethyl-3,3-difluoro-1-propan-2-ylpiperidine;(4R)-4-ethyl-3,3-difluoro-1-propan-2-ylpiperidine;(4-methoxy-1-propan-2-ylpiperidin-4-yl)methanol;(2R)-2-(2-methoxypropan-2-yl)-4-propan-2-ylmorpholine;(2S)-2-(2-methoxypropan-2-yl)-4-propan-2-ylmorpholine;2-(2-methoxypropan-2-yl)-4-propan-2-ylmorpholine;3-propan-2-yloxane;(3R)-3-propan-2-yloxane;(3S)-3-propan-2-yloxane?
The canonical SMILES for (2R)-2-(2-cyclopropylethyl)-4-propan-2-ylmorpholine;(2S)-2-(2-cyclopropylethyl)-4-propan-2-ylmorpholine;3-[[cyclopropyl(methyl)amino]methyl]-1-propan-2-ylpiperidin-3-ol;(3S)-3-[[cyclopropyl(methyl)amino]methyl]-1-propan-2-ylpiperidin-3-ol;(3R)-3-[[cyclopropyl(methyl)amino]methyl]-1-propan-2-ylpiperidin-3-ol;N,N-dimethyl-2-(4-propan-2-yloxan-4-yl)oxyethanamine;4-ethyl-3,3-difluoro-1-propan-2-ylpiperidine;(4S)-4-ethyl-3,3-difluoro-1-propan-2-ylpiperidine;(4R)-4-ethyl-3,3-difluoro-1-propan-2-ylpiperidine;(4-methoxy-1-propan-2-ylpiperidin-4-yl)methanol;(2R)-2-(2-methoxypropan-2-yl)-4-propan-2-ylmorpholine;(2S)-2-(2-methoxypropan-2-yl)-4-propan-2-ylmorpholine;2-(2-methoxypropan-2-yl)-4-propan-2-ylmorpholine;3-propan-2-yloxane;(3R)-3-propan-2-yloxane;(3S)-3-propan-2-yloxane is CC(C)C1(OCCN(C)C)CCOCC1.CC(C)C1CCCOC1.CC(C)C1CCCOC1.CC(C)N1CCCC(O)(CN(C)C2CC2)C1.CC(C)N1CCC[C@@](O)(CN(C)C2CC2)C1.CC(C)N1CCC[C@](O)(CN(C)C2CC2)C1.CC(C)N1CCO[C@@H](CCC2CC2)C1.CC(C)N1CCO[C@H](CCC2CC2)C1.CC(C)[C@@H]1CCCOC1.CCC1CCN(C(C)C)CC1(F)F.CC[C@@H]1CCN(C(C)C)CC1(F)F.CC[C@H]1CCN(C(C)C)CC1(F)F.COC(C)(C)C1CN(C(C)C)CCO1.COC(C)(C)[C@@H]1CN(C(C)C)CCO1.COC(C)(C)[C@H]1CN(C(C)C)CCO1.COC1(CO)CCN(C(C)C)CC1.
What is the InChIKey of (2R)-2-(2-cyclopropylethyl)-4-propan-2-ylmorpholine;(2S)-2-(2-cyclopropylethyl)-4-propan-2-ylmorpholine;3-[[cyclopropyl(methyl)amino]methyl]-1-propan-2-ylpiperidin-3-ol;(3S)-3-[[cyclopropyl(methyl)amino]methyl]-1-propan-2-ylpiperidin-3-ol;(3R)-3-[[cyclopropyl(methyl)amino]methyl]-1-propan-2-ylpiperidin-3-ol;N,N-dimethyl-2-(4-propan-2-yloxan-4-yl)oxyethanamine;4-ethyl-3,3-difluoro-1-propan-2-ylpiperidine;(4S)-4-ethyl-3,3-difluoro-1-propan-2-ylpiperidine;(4R)-4-ethyl-3,3-difluoro-1-propan-2-ylpiperidine;(4-methoxy-1-propan-2-ylpiperidin-4-yl)methanol;(2R)-2-(2-methoxypropan-2-yl)-4-propan-2-ylmorpholine;(2S)-2-(2-methoxypropan-2-yl)-4-propan-2-ylmorpholine;2-(2-methoxypropan-2-yl)-4-propan-2-ylmorpholine;3-propan-2-yloxane;(3R)-3-propan-2-yloxane;(3S)-3-propan-2-yloxane?
The InChIKey is QKUAJTYQLPKVBY-ZDUIGDSTSA-N. The full InChI is InChI=1S/3C13H26N2O.C12H25NO2.2C12H23NO.3C11H23NO2.3C10H19F2N.C10H21NO2.3C8H16O/c3*1-11(2)15-8-4-7-13(16,10-15)9-14(3)12-5-6-12;1-11(2)12(5-8-14-9-6-12)15-10-7-13(3)4;2*1-10(2)13-7-8-14-12(9-13)6-5-11-3-4-11;3*1-9(2)12-6-7-14-10(8-12)11(3,4)13-5;3*1-4-9-5-6-13(8(2)3)7-10(9,11)12;1-9(2)11-6-4-10(8-12,13-3)5-7-11;3*1-7(2)8-4-3-5-9-6-8/h3*11-12,16H,4-10H2,1-3H3;11H,5-10H2,1-4H3;2*10-12H,3-9H2,1-2H3;3*9-10H,6-8H2,1-5H3;3*8-9H,4-7H2,1-3H3;9,12H,4-8H2,1-3H3;3*7-8H,3-6H2,1-2H3/t2*13-;;;2*12-;2*10-;;2*9-;;;8-;;/m10..1010.10..1../s1.
What are the key properties of (2R)-2-(2-cyclopropylethyl)-4-propan-2-ylmorpholine;(2S)-2-(2-cyclopropylethyl)-4-propan-2-ylmorpholine;3-[[cyclopropyl(methyl)amino]methyl]-1-propan-2-ylpiperidin-3-ol;(3S)-3-[[cyclopropyl(methyl)amino]methyl]-1-propan-2-ylpiperidin-3-ol;(3R)-3-[[cyclopropyl(methyl)amino]methyl]-1-propan-2-ylpiperidin-3-ol;N,N-dimethyl-2-(4-propan-2-yloxan-4-yl)oxyethanamine;4-ethyl-3,3-difluoro-1-propan-2-ylpiperidine;(4S)-4-ethyl-3,3-difluoro-1-propan-2-ylpiperidine;(4R)-4-ethyl-3,3-difluoro-1-propan-2-ylpiperidine;(4-methoxy-1-propan-2-ylpiperidin-4-yl)methanol;(2R)-2-(2-methoxypropan-2-yl)-4-propan-2-ylmorpholine;(2S)-2-(2-methoxypropan-2-yl)-4-propan-2-ylmorpholine;2-(2-methoxypropan-2-yl)-4-propan-2-ylmorpholine;3-propan-2-yloxane;(3R)-3-propan-2-yloxane;(3S)-3-propan-2-yloxane?
(2R)-2-(2-cyclopropylethyl)-4-propan-2-ylmorpholine;(2S)-2-(2-cyclopropylethyl)-4-propan-2-ylmorpholine;3-[[cyclopropyl(methyl)amino]methyl]-1-propan-2-ylpiperidin-3-ol;(3S)-3-[[cyclopropyl(methyl)amino]methyl]-1-propan-2-ylpiperidin-3-ol;(3R)-3-[[cyclopropyl(methyl)amino]methyl]-1-propan-2-ylpiperidin-3-ol;N,N-dimethyl-2-(4-propan-2-yloxan-4-yl)oxyethanamine;4-ethyl-3,3-difluoro-1-propan-2-ylpiperidine;(4S)-4-ethyl-3,3-difluoro-1-propan-2-ylpiperidine;(4R)-4-ethyl-3,3-difluoro-1-propan-2-ylpiperidine;(4-methoxy-1-propan-2-ylpiperidin-4-yl)methanol;(2R)-2-(2-methoxypropan-2-yl)-4-propan-2-ylmorpholine;(2S)-2-(2-methoxypropan-2-yl)-4-propan-2-ylmorpholine;2-(2-methoxypropan-2-yl)-4-propan-2-ylmorpholine;3-propan-2-yloxane;(3R)-3-propan-2-yloxane;(3S)-3-propan-2-yloxane has a molecular weight of 3038.73 g/mol, XLogP of 30.21, 46 rotatable bonds, 4 hydrogen bond donors, and 34 hydrogen bond acceptors.
Where does this data come from?
All data for (2R)-2-(2-cyclopropylethyl)-4-propan-2-ylmorpholine;(2S)-2-(2-cyclopropylethyl)-4-propan-2-ylmorpholine;3-[[cyclopropyl(methyl)amino]methyl]-1-propan-2-ylpiperidin-3-ol;(3S)-3-[[cyclopropyl(methyl)amino]methyl]-1-propan-2-ylpiperidin-3-ol;(3R)-3-[[cyclopropyl(methyl)amino]methyl]-1-propan-2-ylpiperidin-3-ol;N,N-dimethyl-2-(4-propan-2-yloxan-4-yl)oxyethanamine;4-ethyl-3,3-difluoro-1-propan-2-ylpiperidine;(4S)-4-ethyl-3,3-difluoro-1-propan-2-ylpiperidine;(4R)-4-ethyl-3,3-difluoro-1-propan-2-ylpiperidine;(4-methoxy-1-propan-2-ylpiperidin-4-yl)methanol;(2R)-2-(2-methoxypropan-2-yl)-4-propan-2-ylmorpholine;(2S)-2-(2-methoxypropan-2-yl)-4-propan-2-ylmorpholine;2-(2-methoxypropan-2-yl)-4-propan-2-ylmorpholine;3-propan-2-yloxane;(3R)-3-propan-2-yloxane;(3S)-3-propan-2-yloxane is sourced from PubChem (CID 167649954), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).